Propaira

Range - Non Confidential Summary

A unique opportunity to license for marketing and distribution a clinically proven cream and cleansing gel for acne prone skin Propaira is a new range of dermatology products, which have been developed to deal with acne prone skin, and are available as a purifying cream and foaming cleansing gel. The Propaira products contain 4% Niacinamide, zinc gluconate and 3% AC NET (cream only). The ingredients have proven ability to reduce pustules and sebum production and the Propaira products are typically used by patients who are controlling the susceptibility of their skin to developing acne. The Propaira range is suitable for use on both male and female skin. Currently available product range: Propaira Purifying Cream 30ml Propaira Foaming Cleanser Gel 100ml USP: The unique formulation of the Propaira range is characterised by 3 key factors as follows: Clinically proven ingredients 4% Niacinamide to combat pimples and blemishes Zinc gluconate - anti-bacterial and anti-irritant activity 3% AC NET (cream only) to reduce sebum production

No common side effects No adverse reaction to sun exposure Can be used on an on-going daily b asis and do not cause irritation, excessive dryness, scarring or bleaching

Simple to use Simple daily use cleanser gel and cream to maintain a clear skin No drug-drug interaction so can be used with other acne products if required For further information, please contact Paul Phull M - +44(0) 7867 782 803 E-mail: pphull@ixal.co.uk

Propaira Range - Non Confidential Summary

A unique opportunity to license for marketing and distribution a clinically proven cream and cleansing gel for acne prone skin Regulatory position In Australia the products are licensed as dermo-cosmetics, promoted to physicians and available in the Pharmacy. Patent / IP position Manufacturing know-how keeps the formulation well protected. Propaira is a global trademark. The Propaira product range was successfully launched in Australia in early 2012 with strong support from dermatologists and is now being offered for sales, marketing and distribution outside Australia. Clinical Evidence: The key ingredients of Propaira are supported by clinical studies as summarised below:

For further information, please contact Paul Phull M - +44(0) 7867 782 803 E-mail: pphull@ixal.co.uk